A
Atara Biotherapeutics, Inc. (ATRA)
NMS – Real Time Price. Currency in USD
9.81
+1.03 (11.73%)
At close: May 12, 2026, 4:00 PM EDT
9.57
-0.24 (-2.45%)
Pre-market: May 13, 2026, 7:04 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
9.81
+1.03 (11.73%)
At close: May 12, 2026, 4:00 PM EDT
9.57
-0.24 (-2.45%)
Pre-market: May 13, 2026, 7:04 AM EDT
No Data
There are no news for this stock.
Total debt $52.8M significantly exceeds cash reserves ($8.5M), raising financial stability concerns
Total current liabilities $14.9M surpass Total current assets $12.2M, signaling liquidity issues
Debt-to-equity ratio (-1.4) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-4.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$5.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.82 | 6.05 | 5.0 | |
| Quick ratio | 0.82 | 5.63 | 5.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 2.41 | 1.04 | 1.0 | |
| Interest coverage | -4.38 | -16.91 | 1.0 | |
| Weighted average score | 2.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 64M | 9M | 129M | 121M | 121M |
| Gross Profit | 49M | -313K | 108M | 100M | 100M |
| Operating Income | -275M | -269M | -78M | 50M | 46M |
| Net Income | -228M | -276M | -85M | 33M | 33M |
| EBITDA | -260M | -264M | -76M | 50M | 48M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -97.04 | -109.42 | 1.0 |
| Next quarter | -76.67 | -228.98 | 1.0 |
| Current year | -86.52 | -126.63 | 1.0 |
| Next year | 212.48 | -13.26 | 5.5 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -53.8 | 20.85 | 21.88 | 41.79 | 7.8 |
| Y/Y | -95.12 | 73.17 | 78.99 | 76.8 | 7.8 |
| 3y average | 437.07 | 62.14 | 62.84 | 39.97 | 10 |
| 5y average | 504.55 | 41.67 | 47.87 | 15.27 | 9.8 |
| Weighted average score | 8.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |